Less than 10 people die from Alzheimer’s disease in Delaware during week ending Feb. 26

Less than 10 people die from Alzheimer’s disease in Delaware during week ending Feb. 26
-
0Comments

There were less than 10 deaths from Alzheimer’s disease reported in Delaware in the week ending Feb. 26, making up less than 7.9 percent of total deaths by all causes in Delaware, according to The Centers for Disease Control and Prevention.

In the week ending Feb. 26, there were 126 deaths in the state. 14.3 percent of deaths were caused by heart disease, 33.3 percent were from cancer and 16.7 percent were from COVID-19.

Studies show doctors and medical examiners may underreport Alzheimer’s disease and dementia-related conditions as the underlying cause of death on death certificates, according to the National Institute on Aging.

Once infected, older adults with dementia are likely to develop a more severe and dangerous illness. The diseases which make an older adult more vulnerable to COVID-19 are age-associated chronic conditions, according to the Bright Focus Foundation.

Delaware top 10 causes of death in week ending Feb. 26

Cause of Death Cause of Death % of Total Deaths
Malignant neoplasms (cancerous tumor) 42 33.3
Heart disease 18 14.3
Cerebrovascular diseases 14 11.1
COVID-19 (multiple cause) 11 8.7
COVID-19 (underlying cause) 10 7.9
Influenza and pneumonia < 10 < 7.9
Nephritis, nephrotic syndrome and nephrosis < 10 < 7.9
Diabetes mellitus < 10 < 7.9
Alzheimer’s disease < 10 < 7.9
Chronic lower respiratory diseases < 10 < 7.9



Related

Benjamin L. Wallace, U.S. Attorney for the District of Delaware

Sussex County man pleads guilty to transporting minor for sexual activity

A Sussex County man has pleaded guilty to transporting a minor across state lines for criminal sexual activity after meeting her online through Snapchat. He faces up to life imprisonment with sentencing set for August.

Benjamin L. Wallace, U.S. Attorney for the District of Delaware

Former Delaware physician agrees to pay $180,000 in genetic testing fraud case

Dr. Shayasta S. Mufti has agreed to pay $180,000 after being accused of ordering unnecessary genetic tests for over 100 Medicare patients without proper examinations or consultations between April and November 2019 in Delaware. Authorities say such actions waste taxpayer money and threaten healthcare program integrity.

Martin A. Makary, M.D. Commissioner of Food and Drugs of FDA

FDA reports lowest Q1 inspection count for biologics companies in Delaware

During the first quarter of 2026, the U.S. Food and Drug Administration (FDA) carried out an inspection at a Biologics company in Delaware.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from First State Times.